Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06335888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Study acronym: CRAFT
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Start date changed from estimate of Jan 2025 to Feb 3, 2025v5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v4
  4. Start date: Jun 2024 to Jan 2025v3
  5. Re-verified, no change to tracked fieldsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this open-label clinical trial is to evaluate the efficacy of AzaFol-PET/CT in the diagnosis of GCA (giant cell arteritis), to compare AzaFol- with 2-\[18F\]FDG-PET/CT, and to assess the safety and tolerability of AzaFol in subjects with suspicion of GCA. Participants will undergo AzaFol-PET/CT imaging at a single timepoint.
Trial Details
NCT Number NCT06335888
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Collaborators: Paul Scherrer Institut, Center for Proton Therapy
Conditions
(from sponsor)		 Giant Cell Arteritis
Related terms Giant Cell Arteritis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov